These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21474491)

  • 81. Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018.
    Fatani N; Fanikos C; Ting C; Buckley LF; Fanikos J
    J Thromb Thrombolysis; 2019 Nov; 48(4):539-541. PubMed ID: 31377965
    [No Abstract]   [Full Text] [Related]  

  • 82. 5-alkyl-1,3-oxazole derivatives of 6-amino-nicotinic acids as alkyl ester bioisosteres are antagonists of the P2Y12 receptor.
    Bach P; Boström J; Brickmann K; Burgess LE; Clarke D; Groneberg RD; Harvey DM; Laird ER; O'Sullivan M; Zetterberg F
    Future Med Chem; 2013 Nov; 5(17):2037-56. PubMed ID: 24215345
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Strategies for targeting the P2Y
    Ma BB; Montgomery AP; Chen B; Kassiou M; Danon JJ
    Bioorg Med Chem Lett; 2022 Sep; 71():128837. PubMed ID: 35640763
    [TBL] [Abstract][Full Text] [Related]  

  • 84. 4-Benzothiazole-7-hydroxyindolinyl diaryl ureas are potent P2Y1 antagonists with favorable pharmacokinetics: low clearance and small volume of distribution.
    Qiao JX; Wang TC; Hiebert S; Hu CH; Schumacher WA; Spronk SA; Clark CG; Han Y; Hua J; Price LA; Shen H; Chacko SA; Everlof G; Bostwick JS; Steinbacher TE; Li YX; Huang CS; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
    ChemMedChem; 2014 Oct; 9(10):2327-43. PubMed ID: 24989964
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Membrane Environment Modulates Ligand-Binding Propensity of P2Y12 Receptor.
    Haghighi F; Yesylevskyy S; Davani S; Ramseyer C
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918934
    [TBL] [Abstract][Full Text] [Related]  

  • 86. P2Y12 receptor involved in the development of chronic nociceptive pain as a sensory information mediator.
    Zhang WJ; Li MY; Wang CY; Feng X; Hu DX; Wu LD; Hu JL
    Biomed Pharmacother; 2023 Aug; 164():114975. PubMed ID: 37267639
    [TBL] [Abstract][Full Text] [Related]  

  • 87. P2Y12 receptor residues crucial for thrombosis regulation.
    Vidhya M
    J Mol Recognit; 2023 Nov; 36(11):e3056. PubMed ID: 37696759
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Do we need a new P2Y12 receptor antagonist?
    Hulot JS; Montalescot G
    Eur Heart J; 2020 Sep; 41(33):3141-3143. PubMed ID: 31845967
    [No Abstract]   [Full Text] [Related]  

  • 89. [Research progress on the impact of morphine on antiplatelet effects of P2Y12 receptor antagonists].
    Cheng NN; Wei YJ; Ding P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Aug; 44(8):734-6. PubMed ID: 27545138
    [No Abstract]   [Full Text] [Related]  

  • 90. Molecular Modeling Applied to the Discovery of New Lead Compounds for P2 Receptors Based on Natural Sources.
    Alberto AVP; da Silva Ferreira NC; Soares RF; Alves LA
    Front Pharmacol; 2020; 11():01221. PubMed ID: 33117147
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Integrating sampling techniques and inverse virtual screening: toward the discovery of artificial peptide-based receptors for ligands.
    Pérez GM; Salomón LA; Montero-Cabrera LA; de la Vega JM; Mascini M
    Mol Divers; 2016 May; 20(2):421-38. PubMed ID: 26553204
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Rare platelet GPCR variants: what can we learn?
    Nisar SP; Jones ML; Cunningham MR; Mumford AD; Mundell SJ;
    Br J Pharmacol; 2015 Jul; 172(13):3242-53. PubMed ID: 25231155
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Identification and analysis of functionally important amino acids in human purinergic 12 receptor using a Saccharomyces cerevisiae expression system.
    Ignatovica V; Megnis K; Lapins M; Schiöth HB; Klovins J
    FEBS J; 2012 Jan; 279(1):180-91. PubMed ID: 22044483
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Ticagrelor for the treatment of arterial thrombosis.
    Gurbel PA; Kereiakes DJ; Tantry US
    Expert Opin Pharmacother; 2010 Sep; 11(13):2251-9. PubMed ID: 20707759
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Docking-based virtual screening of potential human P2Y12 receptor antagonists.
    Chen H; Dong X; Zhou M; Shi H; Luo X
    Acta Biochim Biophys Sin (Shanghai); 2011 May; 43(5):400-8. PubMed ID: 21474491
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Molecular mechanism of action for reversible P2Y12 antagonists.
    Liu H; Ge H; Peng Y; Xiao P; Xu J
    Biophys Chem; 2011 May; 155(2-3):74-81. PubMed ID: 21440362
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Combined 3D-QSAR, molecular docking, and molecular dynamics study on piperazinyl-glutamate-pyridines/pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.
    Hao M; Li Y; Wang Y; Yan Y; Zhang S; Li G; Yang L
    J Chem Inf Model; 2011 Oct; 51(10):2560-72. PubMed ID: 21923153
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.